791 results on '"Lee, Yoo Young"'
Search Results
102. Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma
103. Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings
104. Surgical Outcomes of a New Approach to Laparoscopic Myomectomy: Single-Port and Modified Suture Technique
105. Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: A multicenter review of 114 cases
106. Response to Combination Chemotherapy With Paclitaxel/Ifosfamide/Platinum Versus Paclitaxel/Platinum for Patients With Metastatic, Recurrent, or Persistent Carcinoma of the Uterine Cervix: A Retrospective Analysis
107. Open Scholarship Tools and Platforms at uOttawa
108. Analysis and visualization of the campus web calendar data with R
109. Scoping Study on Open Scholarship and Services by Academic Libraries
110. Clinical outcomes of primary surgical treatment for acquired vulvar lymphangioma circumscriptum
111. Role of salvage radiotherapy for recurrent ovarian cancer
112. Changes in subcellular localization of Lysyl-tRNA synthetase and the 67-kDa laminin receptor in epithelial ovarian cancer metastases
113. Role of reactive thrombocytosis after primary cytoreductive surgery in advanced ovarian cancer
114. The Role of Conization before Radical Hysterectomy in Cervical Cancer including High Risk Factors of Recurrence: Propensity Score Matching
115. Negative effects of antibiotics and low BMI on overall survival of PD-1 inhibitors in patients with recurrent gynecologic malignancies (166)
116. Genetic profiling to predict recurrence of early cervical cancer
117. Overexpression of annexin A4 is associated with chemoresistance in papillary serous adenocarcinoma of the ovary
118. Laparoendoscopic Single-Site Surgery With Hysterectomy in Patients With Prior Cesarean Section: Comparison of Surgical Outcomes With Bladder Dissection Techniques
119. Management and Outcome of Rectal Injury During Gynecologic Laparoscopic Surgery
120. Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer
121. Dynamin 2 expression as a biomarker in grading of cervical intraepithelial neoplasia
122. Clinical significance of changes in peripheral lymphocyte count after surgery in early cervical cancer
123. High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion
124. Angiotensin II type I receptor and miR-155 in endometrial cancers: Synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells
125. Sexual Function after Surgery for Early-Stage Cervical Cancer: Is There a Difference in It According to the Extent of Surgical Radicality?
126. Learning Curves for Single-Site Laparoscopic Ovarian Surgery
127. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: Comparison with SCC-Ag level
128. Diagnostic Accuracy of Loop-Mediated Isothermal Amplification Assay for Group B Streptococcus Detection in Recto-Vaginal Swab: Comparison with Polymerase Chain Reaction Test and Conventional Culture
129. Impact of no residual disease on postoperative computed tomography on survival in patients with optimally debulked advanced high-grade serous ovarian cancer during upfront surgery
130. Prognostic Significance of HER3 Expression in Patients with Cervical Cancer
131. A Matched-Case Comparison to Explore the Role of Consolidation Chemotherapy After Concurrent Chemoradiation in Cervical Cancer
132. What is the learning curve for single-port access laparoscopic-assisted vaginal hysterectomy?
133. Oncologic and reproductive outcomes in patients with advanced-stage borderline ovarian tumors
134. Single-port access (SPA) laparoscopic surgery in gynecology: a surgeon's experience with an initial 200 cases
135. A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB–IIA
136. The expression of the miRNA-200 family in endometrial endometrioid carcinoma
137. Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: A meta-analysis
138. Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy
139. Effect of Waiting Time from Pathological Diagnosis to Definitive Concurrent Chemoradiation for Cervical Cancer on Overall Survival
140. Utility of 3T MRI in Women with IB1 Cervical Cancer in Determining the Necessity of Less Invasive Surgery
141. Where is ERAS in the management of advanced ovarian cancer?: between myths and truths
142. Major clinical research advances in gynecologic cancer in 2021
143. The impact of interval between primary cytoreductive surgery with bowel resection and initiation of adjuvant chemotherapy on survival of women with advanced ovarian cancer: a multicenter cohort study
144. Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy
145. Meta-analysis of the effects of beta blocker on survival time in cancer patients
146. Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin
147. Single port access laparoscopic adnexal surgery versus conventional laparoscopic adnexal surgery: a comparison of peri-operative outcomes
148. Sequence-dependent hematologic side effects of topotecan and cisplatin in persistent or recurrent cervical cancer
149. Factors influencing the choice of laparoscopy or laparotomy in pregnant women with presumptive benign ovarian tumors
150. Postoperative outcomes of MR-invisible stage IB1 cervical cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.